The Second Hospital of Shandong University

Jinan, Shandong 250033

2 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Immunoglobulin A Nephropathy (IgAN), Inflammation, Primary Membranous Nephropathy

Studies at this site

• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — Recruiting now
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed